The Pandemic Is Delaying Cancer Screenings and Detection
The missed checkups could result in later, more severe diagnoses down the line
The missed checkups could result in later, more severe diagnoses down the line
Take a survey and share your experience
Two RNA vaccines will be useful as U.S. infections surge, but the speedy authorizations complicate clinical trials
Deaths are surging, and mental health is strained. But coping strategies people use amid other catastrophes can help
Fears about lingering coronavirus are prompting a massive disinfection initiative before the Bidens move in
Here are pandemic highlights for the week
With the festive season ahead, Nature examines what is known about the risks of COVID spread and how researchers will spend their time off
Emergency use authorizations by the FDA are not ideal
Even with vaccines on the way, treatments are needed to prevent the disease from getting worse—and to be ready for COVID-25, COVID-37, and so on
The country’s leading expert on infectious diseases shares his thoughts on resolving the current public health crisis and preparing for the next
The FDA issued the emergency use authorization for the vaccine late on Friday. And immunizations of health care workers and long-term care facility residents could begin within days...
Here are pandemic highlights for the week
About a year ago, SARS-CoV-2 (which wasn’t called that yet) was just beginning to emerge in a cluster of cases inside China. We know what has happened since then, but it bears repeating: there have been 69 million cases and more than 1.5 million deaths globally as of December 10, 2020, according to the Johns Hopkins Coronavirus Resource Center.And as the virus raced around the world, science has also raced to understand how it actually works, biologically...
Stephen Hahn describes how the agency will evaluate vaccines for emergency authorization
The answer turns out to be complicated
It uses words and photos to remind you of where you’ve been and whom you’ve seen
The incoming U.S. president must help skeptics see benefits in masks and persuade Congress to spend more money on testing and protective gear
Apps and human tracers both have pros and cons. To be effective, they have to work together
Here are pandemic highlights for the week
In the U.S., health workers come first. But for other groups, scientists and policy makers are weighing a mix of disease risks, logistics and ethics
You have free articles left.
Support our award-winning coverage of advances in science & technology.
Already a subscriber? Sign in.